Clinical Trials
5 trialsNCT00639639 2023-03-13
ATTAC
Duke University
Phase 1 Completed
NCT02864368 2022-06-09
PERFORMANCE
Duke University
Phase 1 Terminated
NCT01644968 2022-05-17
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Providence Health & Services
Phase 1 Completed
NCT03615404 2021-01-28
ATTAC-P
Duke University
Phase 1 Completed
NCT00369291 2017-11-29
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated